A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0843
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer ; volume:67 ; number:4 ; day:3 ; month:6 ; year:2010 ; pages:751-764 ; date:4.2011
Cancer chemotherapy and pharmacology ; 67, Heft 4 (3.6.2010), 751-764, 4.2011
- Urheber
-
Tolcher, Anthony W.
Appleman, Leonard J.
Shapiro, Geoffrey I.
Mita, Alain C.
Cihon, Frank
Mazzu, Arthur
Sundaresan, Pavur R.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00280-010-1372-3
- URN
-
urn:nbn:de:101:1-2019111703261883770064
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tolcher, Anthony W.
- Appleman, Leonard J.
- Shapiro, Geoffrey I.
- Mita, Alain C.
- Cihon, Frank
- Mazzu, Arthur
- Sundaresan, Pavur R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma
Atezolizumab plus Bevacizumab versus Sorafenib in the Chinese Subpopulation with Unresectable Hepatocellular Carcinoma: Phase 3 Randomized, Open-Label IMbrave150 Study
An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorder
PHOCUS: A Phase 3, Randomized, Open-Label Study of Sequential Treatment with Pexa-Vec (JX-594) and Sorafenib in Patients with Advanced Hepatocellular Carcinoma
Cardiovascular events by different target hemoglobin levels in ESA-hyporesponsive hemodialysis patients: a multicenter, open-label, randomized controlled study
IGF-1 in autosomal dominant cerebellar ataxia - open-label trial
Effects of practicing yoga on alexisomia: an open-label trial
A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis
Safety of Rimegepant in Adults with Migraine and Cardiovascular Risk Factors: Analysis of a Multicenter, Long-Term, Open-Label Study
An open-label feasibility trial of transdermal cannabidiol for hand osteoarthritis
Open-label placebos for menopausal hot flushes: a randomized controlled trial
Open-label placebos reduce weight in obesity: a randomized controlled trial
HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma
Atezolizumab plus Bevacizumab versus Sorafenib in the Chinese Subpopulation with Unresectable Hepatocellular Carcinoma: Phase 3 Randomized, Open-Label IMbrave150 Study
An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorder
PHOCUS: A Phase 3, Randomized, Open-Label Study of Sequential Treatment with Pexa-Vec (JX-594) and Sorafenib in Patients with Advanced Hepatocellular Carcinoma
Cardiovascular events by different target hemoglobin levels in ESA-hyporesponsive hemodialysis patients: a multicenter, open-label, randomized controlled study
IGF-1 in autosomal dominant cerebellar ataxia - open-label trial
Effects of practicing yoga on alexisomia: an open-label trial
A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis
Safety of Rimegepant in Adults with Migraine and Cardiovascular Risk Factors: Analysis of a Multicenter, Long-Term, Open-Label Study
An open-label feasibility trial of transdermal cannabidiol for hand osteoarthritis
Open-label placebos for menopausal hot flushes: a randomized controlled trial
Open-label placebos reduce weight in obesity: a randomized controlled trial
HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma
Atezolizumab plus Bevacizumab versus Sorafenib in the Chinese Subpopulation with Unresectable Hepatocellular Carcinoma: Phase 3 Randomized, Open-Label IMbrave150 Study
An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorder
PHOCUS: A Phase 3, Randomized, Open-Label Study of Sequential Treatment with Pexa-Vec (JX-594) and Sorafenib in Patients with Advanced Hepatocellular Carcinoma
Cardiovascular events by different target hemoglobin levels in ESA-hyporesponsive hemodialysis patients: a multicenter, open-label, randomized controlled study
IGF-1 in autosomal dominant cerebellar ataxia - open-label trial
Effects of practicing yoga on alexisomia: an open-label trial
A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis
Safety of Rimegepant in Adults with Migraine and Cardiovascular Risk Factors: Analysis of a Multicenter, Long-Term, Open-Label Study
An open-label feasibility trial of transdermal cannabidiol for hand osteoarthritis
Open-label placebos for menopausal hot flushes: a randomized controlled trial